New research from Roche UK has revealed that 82% of Generation Z, the age group encompassing 16 to 24 year olds, want to see the NHS introduce digital solutions to better manage their health and improve care.
The Cell and Gene Therapy (CGT) Catapult has launched the first Advanced Therapy Medicinal Products (ATMP) focused apprenticeship programme, developed in partnership with The Medicine Manufacturing Industry Partnership (MMIP).
The Association of the British Pharmaceutical Industry has agreed the terms of the 2019 Pharmaceutical Price Regulation Scheme (PPRS) with the government, which is expected to come into effect from January.
The House of Lords EU Home Affairs Sub-Committee has written to health secretary Matt Hancock asking for clarity on the government’s contingency preparations to ensure the UK has continued access to medicines and medical products in the event of a ‘no deal’ Brexit.
The government has announced plans to inject an extra £3.5 billion a year into primary and community healthcare by 2023/24, calling the investment a “historic commitment” to increasing the proportion of NHS funding spent on primary and community services.